Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study
- PMID: 37201114
- PMCID: PMC10185820
- DOI: 10.3389/fcimb.2023.1171517
Causal effects between gut microbiota and IgA nephropathy: a bidirectional Mendelian randomization study
Abstract
Background: Therapeutic approaches that target the gut microbiota (GM) may be helpful in the potential prevention and treatment of IgA nephropathy (IgAN). Meanwhile, relevant studies demonstrated a correlation between GM and IgAN, however, these confounding evidence cannot prove a causal relationship between GM and IgAN.
Methods: Based on the data from the GM genome-wide association study (GWAS) of MiBioGen and the IgAN GWAS data from the FinnGen research. A bi-directional Mendelian randomization (MR) study was performed to explore the causal relationship between GM and IgAN. We used inverse variance weighted (IVW) method as the primary method to determine the causal relationship between exposure and outcome in our MR study. Besides, we used additional analysis (MR-Egger, weighted median) and sensitivity analysis (Cochrane's Q test, MR-Egger and MR-PRESSO) to select significant results, followed by Bayesian model averaging (MR-BMA) to test the results of MR study. Finally, a reverse MR analysis was conducted to estimate the probability of reverse causality.
Results: At the locus-wide significance level, the results of IVW method and additional analysis showed that Genus Enterorhabdus was a protective factor for IgAN [OR: 0.456, 95% CI: 0.238-0.875, p=0.023], while Genus butyricicoccus was a risk factor for IgAN [OR: 3.471, 95% CI: 1.671-7.209, p=0.0008]. In the sensitivity analysis, no significant pleiotropy or heterogeneity of the results was found.
Conclusion: Our study revealed the causal relationship between GM and IgAN, and expanded the variety of bacterial taxa causally related to IgAN. These bacterial taxa could become novel biomarkers to facilitate the development of targeted therapies for IgAN, developing our understanding of the "gut-kidney axis".
Keywords: Bayesian model averaging; IgA nephropathy; causality; gut microbiota; pathogenesis; two-sample mendelian randomization.
Copyright © 2023 Ren, Jin, Liu, Ren and Zhan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation.Nutrients. 2023 May 22;15(10):2407. doi: 10.3390/nu15102407. Nutrients. 2023. PMID: 37242290 Free PMC article.
-
Causal relationships between gut microbiota and IgA nephropathy: evidence from Mendelian randomization and microbiome validation.Ren Fail. 2025 Dec;47(1):2522979. doi: 10.1080/0886022X.2025.2522979. Epub 2025 Jun 25. Ren Fail. 2025. PMID: 40563121
-
Gut microbiota and intervertebral disc degeneration: a bidirectional two-sample Mendelian randomization study.J Orthop Surg Res. 2023 Aug 14;18(1):601. doi: 10.1186/s13018-023-04081-0. J Orthop Surg Res. 2023. PMID: 37580794 Free PMC article.
-
The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study.Trials. 2025 Mar 24;26(1):101. doi: 10.1186/s13063-025-08755-4. Trials. 2025. PMID: 40122887 Free PMC article. Review.
-
Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study.Front Cell Infect Microbiol. 2024 May 22;14:1348685. doi: 10.3389/fcimb.2024.1348685. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38841114 Free PMC article.
Cited by
-
Changes in the Progression of Chronic Kidney Disease in Patients Undergoing Fecal Microbiota Transplantation.Nutrients. 2024 Apr 10;16(8):1109. doi: 10.3390/nu16081109. Nutrients. 2024. PMID: 38674803 Free PMC article. Clinical Trial.
-
Association between gut microbiota and diabetic nephropathy: a mendelian randomization study.Front Microbiol. 2024 Mar 27;15:1309871. doi: 10.3389/fmicb.2024.1309871. eCollection 2024. Front Microbiol. 2024. PMID: 38601939 Free PMC article.
-
Genetically Predicted Causal Relationship between Gut Microbiota and Various Kidney Diseases.Kidney Dis (Basel). 2025 Feb 27;11(1):170-185. doi: 10.1159/000544915. eCollection 2025 Jan-Dec. Kidney Dis (Basel). 2025. PMID: 40191763 Free PMC article.
-
Impact of gut microbiota in chronic kidney disease: natural polyphenols as beneficial regulators.Ren Fail. 2025 Dec;47(1):2506810. doi: 10.1080/0886022X.2025.2506810. Epub 2025 May 29. Ren Fail. 2025. PMID: 40441674 Free PMC article. Review.
-
Causal effects of 731 immune cell phenotypes on autism spectrum disorder: a Mendelian randomization study.Front Psychiatry. 2024 May 16;15:1397006. doi: 10.3389/fpsyt.2024.1397006. eCollection 2024. Front Psychiatry. 2024. PMID: 38827447 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous